THEY SAID IT! SENATE JUDICIARY CALLS OUT BIG PHARMA’S ANTI-COMPETITIVE PRACTICES THAT KEEP PRESCRIPTION DRUG PRICES HIGH
Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s… Read More
Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s… Read More
Committee Markup Advances Legislation to Crack Down on Big Pharma’s… Read More
Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute… Read More
BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION… Read More
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More
Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and… Read More
U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious… Read More
Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More
Voters Across the Political Spectrum Identify Pharmaceutical Company Profits… Read More
Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather… Read More
Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are… Read More
Campaign Looks Forward to Working with Kennedy and the Administration to Lower… Read More